Skip to main content
. 2025 Jul 16;14(14):1084. doi: 10.3390/cells14141084
8-OHdG 8-oxodeoxyguanosine
AG androgen receptor
BPD bronchopulmonary dysplasia
CCL C-C motif chemokine ligand
COX-2 cyclooxygenase-2
DAMPs damage-associated molecular patterns
DOHaD developmental origins of health and disease
E embryonic day
EVs extracellular vesicles
Fe2+ ferrous iron
GWAS genome-wide associated studies
GM-CSF granulocyte–macrophage colony stimulating factor
GnRH gonadotropin-releasing hormone
GPX glutathione peroxidase
GR glucocorticoid receptor
GRER1 G-protein-coupled estrogen receptor 1
GSH glutathione
H2O2 hydrogen peroxide
hCG human chorionic gonadotropin
HIF hypoxia-inducible factor
HO heme oxygenase
HO˙ hydroxyl radical
IFN interferon
Ig immunoglobulin
IGF insulin-like growth factor
IL interleukin
IUGR intrauterine growth restriction
MAPK p38-mitogen-activated protein kinase
MDA malondialdehyde
MIAC microbial invasion of amniotic cavity
MMP matrix metalloproteinase-9
NF-κb nuclear factor kappa-light-chain-enhancer of activated B cell
NK natural killer
nRBCs nucleated red blood cells
O2 superoxide radical
P4 progesterone
PAMPs pathogen-associated molecular patterns
PAPP pregnancy-associated plasma protein
PE preeclampsia
PG prostaglandin
PlGF placental growth factor
PIVH periventricular–intraventricular hemorrhage
pPROM preterm premature rupture of the membrane
PRA progesterone receptor A
PTB preterm birth
RDS respiratory distress syndrome
ROS reactive oxygen species
SOD superoxide dismutase
SpAs spiral arteries
sPTB spontaneous preterm birth
SRY sex-determining region
T1 trimester 1
T2 trimester 2
T3 trimester 3
TLR toll-like receptor
TNF tumor necrosis factor
Vegf vascular endothelial growth factor
XCI X chromosome inhibition